Condition: ADHD - Attention Deficit Disorder With Hyperactivity · Sponsor: Psychiatric Research Unit, Region Zealand, Denmark
The investigators will assess the use of the Monarch eTNS device as a non-pharmacological treatment for patients aged 7 to 17 years with ADHD. The investigators will compare the eTNS device to a sham device. Participants will use the device for four weeks during night time. During the trial, participants will receive different questionaires to assess symptoms and will also keep a logbook to record their experience with the device. At the end of trial, the investigators will assess what the families thought of the device, and whether it is indeed feasible to further explore the effect of the device in a larger clinical trial.
This description comes directly from the study's public registry record.
Ole Jakob Storebø, Professor · 452-496-5917 · ojst@regionsjaelland.dk
Henriette Edemann-Callesen, Phd, MD · 452-834-3531 · henriette.callesen@gmail.com
Always discuss trial participation with your own doctor first.
| Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, 4200 Slagelse, Denmark | Slagelse, Region Sjælland, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06655610